Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-06

Clinical Trial Update: China Refractory Obsessive-Compulsive Disorder Deep Brain Stimulation Study [Phase 2, Phase 3]

View source ↗

Summary

A China-based deep brain stimulation trial for refractory obsessive-compulsive disorder (Phase 2/3) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ruijin Hospital | Conditions: Obsessive Compulsive Disorder | Phase 2, Phase 3 | Status: WITHDRAWN